A new study from the INTERVENE consortium has evaluated genome-wide risk prediction of common diseases across multiple ancestries in one million people.

International research consortia have analyzed common and rare DNA variants in hundreds of thousands of people, revealing clearest genetic signals yet for schizophrenia risk.